THE ENIGMA OF HLA-MEDIATED ADVERSE DRUG REACTIONS: EPOXIDE BUT NOT CARBAMAZEPINE INDUCES THE BINDING OF HAPTENATED PEPTIDES TO HLA-B*15:02

被引：0

作者：

Simper, Gwendolin S. ^{[1
]}

Celik, Alexander A. ^{[1
]}

Ho, Gia-Gia T. ^{[1
]}

Huyton, Trevor ^{[2
]}

Kuhn, Joachim ^{[3
]}

Blasczyk, Rainer ^{[1
]}

Bade-Doeding, Christina ^{[1
]}

机构：

[1] Hannover Med Sch, Hannover, Germany

[2] Max Planck Inst, Gottingen, Germany

[3] Heart & Diabet Ctr North Rhine Westphalia, Bad Oeynhausen, Germany

来源：

HLA | 2018年 / 91卷 / 05期

关键词：

D O I：

暂无

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：322 / 322

页数：1

共 50 条

[21] HLA-A*31: 01 and HLA-B*15:02 are not associated with cutaneous adverse reactions induced by aromatic antiseizure medication in a Brazilian population [J].

Spina Tensini, Tallulah ;

Bettinotti, Maria P. ;

Iglehart, Brian ;

da Silva Arndt, Raquel Cristina ;

de Queiroz von Glehn, Cristina ;

Soares Silvado, Carlos Eduardo .

EPILEPSIA, 2021, 62 :214-214

[22] Evaluation of tagged SNPs for HLA markers, HLA-B*15:02 and HLA-A*31:01, that are used to predict carbamazepine induced adverse effects (vol 35, 17, 2025) [J].

Kaul-Ghanekar, Ruchika ;

Kulkarni, Maushumi .

PHARMACOGENETICS AND GENOMICS, 2025, 35 (02) :87

[23] HLA-B*5701 and HLA-B*5801 in an Indian patient with anti-epileptics induced cutaneous adverse drug reactions [J].

Aarthi Manoharan ;

Ajay Sam Kumar ;

Ambujam Sreedevi ;

Aruna Devi Sathishkannan ;

Bhargav Kiran Gaddam .

European Journal of Clinical Pharmacology, 2019, 75 :599-601

[24] HLA-B*5701 and HLA-B*5801 in an Indian patient with anti-epileptics induced cutaneous adverse drug reactions [J].

Manoharan, Aarthi ;

Kumar, Ajay Sam ;

Sreedevi, Ambujam ;

Sathishkannan, Aruna Devi ;

Gaddam, Bhargav Kiran .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (04) :599-601

[25] Comparison of a New In-House and Three Published HLA-B*15:02 Screening Methods for Prevention of Carbamazepine-Induced Severe Drug Reactions [J].

Jaruthamsophon, Kanoot ;

Sripo, Thanya ;

Sukasem, Chonlaphat ;

Limprasert, Pornprot .

PLOS ONE, 2016, 11 (05)

[26] External quality assessment for laboratory testing of HLA-B*15:02 allele in relation to carbamazepine therapy [J].

Lin, Guigao ;

Zhang, Kuo ;

Han, Yanxi ;

Xie, Jiehong ;

Li, Jinming .

JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (02)

[27] THE ASSOCIATION BETWEEN CARBAMAZEPINE-INDUCED CUTANEOUS ADVERSE DRUG REACTIONS WITH HLA-B*1502 ALLELE IN MAINLAND OF CHINA [J].

Wu, X. ;

An, D. ;

Hu, F. ;

Stefan, H. ;

Zhou, D. .

EPILEPSIA, 2010, 51 :2-2

[28] Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population [J].

Tassaneeyakul, Wichittra ;

Tiamkao, Somsak ;

Jantararoungtong, Thawinee ;

Chen, Pei ;

Lin, Shu-Yi ;

Chen, Wei-Hsuan ;

Konyoung, Parinya ;

Khunarkornsiri, Usanee ;

Auvichayapat, Narong ;

Pavakul, Kasemsin ;

Kulkantrakorn, Kongkiat ;

Choonhakarn, Charoen ;

Phonhiamhan, Siranun ;

Piyatrakul, Namfon ;

Aungaree, Thiti ;

Pongpakdee, Sunsanee ;

Yodnopaglaw, Praphan .

EPILEPSIA, 2010, 51 (05) :926-930

[29] ASSOCIATION OF HLA-B*15:02 ALLELE WITH LAMOTRIGINE-INDUCED CUTANEOUS ADVERSE DRUG REACTION IN AN INDIAN PATIENT [J].

Misra, Maneesh K. ;

Upchurch, Rebecca L. ;

Weidner, Jerome G. ;

Pullen, Bianca ;

Lee, Royce ;

Brown, Nicholas K. ;

Marino, Susana R. .

HUMAN IMMUNOLOGY, 2019, 80 :55-55

[30] Association of HLA-A*11:01, HLA-B*39:01, and HLA-B*56:03 with salazosulfapyridine-induced cutaneous adverse drug reactions [J].

Fukunaga, Koya ;

Tsukagoshi, Eri ;

Nakamura, Ryosuke ;

Matsunaga, Kayoko ;

Ozeki, Takeshi ;

Watanabe, Hideaki ;

Hasegawa, Akito ;

Hama, Natsumi ;

Kurata, Maiko ;

Mizukawa, Yoshiko ;

Watanabe, Yuko ;

Yamaguchi, Yukie ;

Niihara, Hiroyuki ;

Morita, Eishin ;

Asada, Hideo ;

Abe, Riichiro ;

Saito, Yoshiro ;

Mushiroda, Taisei .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (05) :1355-1358.e3

← 1 2 3 4 5 →